CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Common Stock [Member]	Series A Preferred Stock [Member]	Series B Preferred Stock [Member]	Series D Preferred Stock [Member]	Series E Preferred Stock [Member]	Series F Preferred Stock [Member]	Additional Paid In Capital [Member]	Accumulated Other Comprehensive Income [Member]	Accumulated Deficit [Member]	Total
BALANCE AT BEGINING at Apr. 29, 2016	$ 10,023				$ 1,000					$ 11,023
BALANCE AT BEGINING (in shares) at Apr. 29, 2016	10,022,543				1,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss									$ (3,502,005)	(3,502,005)
Common stock issued for conversion of convertible note payable	$ 3,498						$ 31,483			34,981
Common stock issued for conversion of convertible note payable (in shares)	3,498,124
Common stock issued for reverse merger	$ 20,000						(401,444)			(381,444)
Common stock issued for reverse merger (in shares)	20,000,000
Preferred stock issued for intellectual property		$ 2,990,535								2,990,535
Preferred stock issued for intellectual property (in shares)		5,000,000
Imputed interest							3,822			3,822
Beneficial conversion discount on convertible note payable
BALANCE AT END at Sep. 30, 2016	$ 33,521	$ 2,990,535			$ 1,000		(366,139)		(3,502,005)	(843,088)
BALANCE AT END (in shares) at Sep. 30, 2016	33,520,667	5,000,000			1,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss									(1,679,789)	(1,679,789)
Stock compensation							199,870			199,870
Common stock issued for conversion of convertible note payable	$ 10,263						120,856			131,119
Common stock issued for conversion of convertible note payable (in shares)	10,263,400
Common stock issued for reverse merger	$ 1,800						106,050			107,850
Common stock issued for reverse merger (in shares)	1,800,000
Series B Preferred Stock issued for cash			$ 30				29,970			30,000
Series B Preferred Stock issued for cash (in shares)			30,000
Series D and F Stock issued for conversion of convertible notes payable				$ 510		$ 472	1,403,051			1,404,033
Series D and F Stock issued for conversion of convertible notes payable (in shares)				509,988		471,975
Other comprehensive loss								$ (970)		(970)
Beneficial conversion discount on convertible note payable							27,000			27,000
BALANCE AT END at Sep. 30, 2017	$ 45,584	$ 2,990,535	$ 30	$ 510	$ 1,000	$ 472	$ 1,520,658	$ (970)	$ (5,181,794)	$ (623,975)
BALANCE AT END (in shares) at Sep. 30, 2017	45,584,067	5,000,000	30,000	509,988	1,000,000	471,975